Dextromethorphan HBr 60 mg / guaiFENesin 800 mg / phenylpropanolamine HCl 75 mg 12HR Extended Release Oral Tablet
RxNorm 2168515
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2168515 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: dextromethorphan HBr 60 mg / guaiFENesin 800 mg / phenylpropanolamine HCl 75 mg 12HR Extended Release Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
12 HR dextromethorphan hydrobromide 60 mg / guaifenesin 800 mg / phenylpropanolamine hydrochloride 75 mg Extended Release Oral Tablet
(Atom ID: 12401416)
TMSY
Tall Man Lettering Synonym (TMSY):
12 HR dextromethorphan hydrobromide 60 mg / guaiFENesin 800 mg / phenylpropanolamine hydrochloride 75 mg Extended Release Oral Tablet
(Atom ID: 12403520)
SY
Synonym (SY):
Dextromethorphan HBr 60 mg / guaifenesin 800 mg / phenylpropanolamine HCl 75 mg 12 HR Extended Release Oral Tablet
(Atom ID: 12401419)
TMSY
Tall Man Lettering Synonym (TMSY):
Dextromethorphan HBr 60 mg / guaiFENesin 800 mg / phenylpropanolamine HCl 75 mg 12 HR Extended Release Oral Tablet
(Atom ID: 12403525)
PSN